We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App


24 Feb 2024 - 28 Feb 2024
05 Mar 2024 - 07 Mar 2024

Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions

By LabMedica International staff writers
Posted on 14 Aug 2023
Print article
Image: A new study has linked part of CBC with risk of hospital admission and in-hospital mortality (Photo courtesy of Shutterstock)
Image: A new study has linked part of CBC with risk of hospital admission and in-hospital mortality (Photo courtesy of Shutterstock)

Red blood cell distribution width (RDW), an integral component of the complete blood count (CBC) panel, measures the variation in red blood cell size. Increased RDW levels have demonstrated a relation to unfavorable patient outcomes across a range of diseases, spanning from heart attacks to COVID-19 pneumonia. Recent research has identified RDW as a generalizable biomarker for emergency department (ED) acuity. However, there have been few studies to examine the prognostic value of RDW within the ED setting. Previous studies have mainly focused on specific diseases like acute coronary syndrome, deep vein thrombosis, and sepsis, often employing limited sample sizes ranging from hundreds to thousands of patients. Now, a new study using a large dataset of ED visits has revealed that higher RDW value in the ED is correlated to hospital admission and, in individuals admitted to the hospital, in-hospital mortality.

Researchers in the Department of Emergency Medicine at UCLA David Geffen School of Medicine (Los Angeles, CA, USA) conducted a retrospective analysis of over 200,000 adult ED visits with CBC results between the period March 2013 and February 2022. The study’s key objective was to investigate the correlation between initial RDW measurements obtained during ED visits and two crucial outcomes: hospital admission and in-hospital mortality. The study revealed that elevated RDW levels were notably prevalent in visits culminating in hospital admission. Moreover, among admitted patients, those necessitating intensive care unit (ICU) care or experiencing in-hospital mortality exhibited even higher RDW values.

An RDW value of more than 16 demonstrated a specificity of 90% for predicting hospital admission, while an RDW value exceeding 18.5 demonstrated 90% specificity for predicting in-hospital mortality. These findings are in line with prior studies that have linked heightened RDW levels to higher mortality risks in conditions such as myocardial infarction, pulmonary embolism, heart failure, sepsis, and COVID-19. However, the latest study establishes a relation between RDW and overall hospital admissions as well as in-hospital mortality across all-cause adult ED visits. According to the researchers, while elevated RDW alone might not possess the sensitivity required for a comprehensive diagnostic tool, combining it with other clinical data could substantially enhance clinicians' capacity to predict hospital admissions and identify patients at heightened risk of in-hospital mortality.

Related Links:
UCLA David Geffen School of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control

Print article


Clinical Chemistry

view channel
Image: Wireless Point-of-Care Testing for Hepatitis B Virus (Photo courtesy of Chulalongkorn University)

Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step

Hepatitis B, a significant global health concern, is responsible for chronic liver diseases like cirrhosis and liver cancer which is one of the most common cancers worldwide. The challenge with hepatitis... Read more

Molecular Diagnostics

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is an autoimmune disorder that typically presents as venous or arterial thrombosis and/or pregnancy loss. Diagnosing APS can be difficult as its symptoms often resemble... Read more


view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more


view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.